These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16395687)

  • 21. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
    Oren I; Haddad N; Finkelstein R; Rowe JM
    Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.
    Maertens J; Van Eldere J; Verhaegen J; Verbeken E; Verschakelen J; Boogaerts M
    J Infect Dis; 2002 Nov; 186(9):1297-306. PubMed ID: 12402199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients.
    Jantunen E; Salonen J; Juvonen E; Koivunen E; Siitonen T; Lehtinen T; Kuittinen O; Leppä S; Anttila VJ; Itälä M; Wiklund T; Remes K; Nousiainen T
    Eur J Haematol; 2004 Sep; 73(3):174-8. PubMed ID: 15287914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
    Dvorak CC; Steinbach WJ; Brown JM; Agarwal R
    Bone Marrow Transplant; 2005 Oct; 36(7):621-9. PubMed ID: 16044133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
    Cornely OA; Böhme A; Reichert D; Reuter S; Maschmeyer G; Maertens J; Buchheidt D; Paluszewska M; Arenz D; Bethe U; Effelsberg J; Lövenich H; Sieniawski M; Haas A; Einsele H; Eimermacher H; Martino R; Silling G; Hahn M; Wacker S; Ullmann AJ; Karthaus M;
    J Antimicrob Chemother; 2008 Apr; 61(4):939-46. PubMed ID: 18272515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.
    Blennow O; Remberger M; Klingspor L; Omazic B; Fransson K; Ljungman P; Mattsson J; Ringdén O
    Bone Marrow Transplant; 2010 Dec; 45(12):1710-8. PubMed ID: 20190840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of acute leukemia complicated by invasive aspergillosis in children].
    Liu Y; Tang SQ; Wang JW; Long H; Feng C; Zhang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):901-4. PubMed ID: 20113657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
    Ribera JM; Ortega JJ; Oriol A; Bastida P; Calvo C; Pérez-Hurtado JM; González-Valentín ME; Martín-Reina V; Molinés A; Ortega-Rivas F; Moreno MJ; Rivas C; Egurbide I; Heras I; Poderós C; Martínez-Revuelta E; Guinea JM; del Potro E; Deben G
    J Clin Oncol; 2007 Jan; 25(1):16-24. PubMed ID: 17194902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer.
    Woods G; Miceli MH; Grazziutti ML; Zhao W; Barlogie B; Anaissie E
    Cancer; 2007 Aug; 110(4):830-4. PubMed ID: 17607669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.
    Saarinen-Pihkala UM; Heilmann C; Winiarski J; Glomstein A; Abrahamsson J; Arvidson J; Békássy AN; Forestier E; Jonmundsson G; Schroeder H; Vettenranta K; Wesenberg F; Gustafsson G
    J Clin Oncol; 2006 Dec; 24(36):5750-62. PubMed ID: 17179109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of invasive fungal infections using real-time PCR assay in paediatric acute leukaemia induction.
    Mandhaniya S; Iqbal S; Sharawat SK; Xess I; Bakhshi S
    Mycoses; 2012 Jul; 55(4):372-9. PubMed ID: 22420668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
    Einsele H; Loeffler J
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.
    Hebart H; Klingspor L; Klingebiel T; Loeffler J; Tollemar J; Ljungman P; Wandt H; Schaefer-Eckart K; Dornbusch HJ; Meisner C; Engel C; Stenger N; Mayer T; Ringden O; Einsele H
    Bone Marrow Transplant; 2009 Apr; 43(7):553-61. PubMed ID: 19079316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan.
    Kobayashi R; Kaneda M; Sato T; Ichikawa M; Suzuki D; Ariga T
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):886-90. PubMed ID: 19131772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases.
    Yoo JH; Choi JH; Choi SM; Lee DG; Shin WS; Min WS; Kim CC
    Clin Infect Dis; 2005 Feb; 40(3):392-8. PubMed ID: 15668862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.